![Aleksandrs Zhavoronkov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aleksandrs Zhavoronkov
Directeur Général chez
INSILICO MEDICINE CAYMAN TOPCO
Fortune : 327 M $ au 30/09/2026
Profil
Aleksandrs Zhavoronkov is the founder of InSilico Medicine Hong Kong Ltd., founded in 2014, holding the title of Co-Chief Executive Officer & Director.
Dr. Zhavoronkov was the founder of Deep Longevity Ltd., founded in 2020, holding the title of Co-Chief Executive Officer.
Dr. Zhavoronkov is the founder of InSilico Medicine, Inc., founded in 2014, holding the title of Co-Chief Executive Officer & Director.
Dr. Zhavoronkov is the founder of InSilico Medicine Cayman TopCo, founded in 2018, holding the title of Chairman & Co-Chief Executive Officer.
Dr. Zhavoronkov is the founder of LongeVC, founded in 2016, holding the title of Head of Advisory Board.
Dr. Zhavoronkov is also the founder of Insilicon Intelligent Technology (Shanghai) Co., Ltd.,Insilico Medicine IP Ltd...
Dr. Zhavoronkov is currently Director at Alliance For Artificial Intelligence In Healthcare.
Dr. Zhavoronkov is currently Trustee at Biogerontology Research Foundation.
Former positions include Sales Director at ATI Technologies ULC, Director-Business Development at Colby Pharmaceutical Co. from 2008 to 2009, and President at Mediox, Inc. Education includes an undergraduate degree from Queen's University conferred in 2009, a graduate degree from The Johns Hopkins University, and a doctorate from Moscow State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/09/2026 | 42 697 000 ( 7,33 % ) | 327 M $ | 30/09/2026 |
Postes actifs de Aleksandrs Zhavoronkov
| Sociétés | Poste | Début |
|---|---|---|
| INSILICO MEDICINE CAYMAN TOPCO | Directeur Général | 19/11/2018 |
Biogerontology Research Foundation | Directeur/Membre du Conseil | 17/09/2009 |
InSilico Medicine Hong Kong Ltd.
 InSilico Medicine Hong Kong Ltd. Packaged SoftwareTechnology Services Develops AI software for drug discovery | Fondateur | 01/01/2014 |
Insilico Medicine IP Ltd.
 Insilico Medicine IP Ltd. BiotechnologyHealth Technology Engages in research and development of drugs | Directeur Général | - |
Alliance For Artificial Intelligence In Healthcare
 Alliance For Artificial Intelligence In Healthcare Packaged SoftwareTechnology Services Develops artificial intelligence software for pharmaceutical company | Directeur/Membre du Conseil | - |
InSilico Medicine, Inc.
 InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Fondateur | 01/01/2014 |
LongeVC
 LongeVC Investment ManagersFinance LongeVC invests in ageless future companies located across the globe. The firm target companies operating in the fields of therapeutics, diagnostics & prevention and Longevity Infrastructure sectors. It provides financing for early stage transactions. | Fondateur | 01/01/2016 |
Anciens postes connus de Aleksandrs Zhavoronkov
| Sociétés | Poste | Fin |
|---|---|---|
Deep Longevity Ltd.
 Deep Longevity Ltd. Packaged SoftwareTechnology Services Develops artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system and psychological levels | Fondateur | 01/01/2023 |
Colby Pharmaceutical Co.
 Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for treating prostate and other hypoxic solid tumors | Corporate Officer/Principal | 01/01/2009 |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | - |
Formation de Aleksandrs Zhavoronkov
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
ATI Technologies ULC
 ATI Technologies ULC SemiconductorsElectronic Technology Designs, makes and sells graphics accelerators & multimedia solutions | Electronic Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moscow State University
 Moscow State University Other Consumer ServicesConsumer Services College/University | Consumer Services |
Colby Pharmaceutical Co.
Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for treating prostate and other hypoxic solid tumors | Health Technology |
Mediox, Inc. | |
Biogerontology Research Foundation | |
InSilico Medicine Hong Kong Ltd.
InSilico Medicine Hong Kong Ltd. Packaged SoftwareTechnology Services Develops AI software for drug discovery | Technology Services |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Technology Services |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Pharmaceuticals: MajorHealth Technology Develops therapeutic pipeline technology and AI software platform | Health Technology |
Alliance For Artificial Intelligence In Healthcare
Alliance For Artificial Intelligence In Healthcare Packaged SoftwareTechnology Services Develops artificial intelligence software for pharmaceutical company | Technology Services |
Deep Longevity Ltd.
Deep Longevity Ltd. Packaged SoftwareTechnology Services Develops artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system and psychological levels | Technology Services |
LongeVC
LongeVC Investment ManagersFinance LongeVC invests in ageless future companies located across the globe. The firm target companies operating in the fields of therapeutics, diagnostics & prevention and Longevity Infrastructure sectors. It provides financing for early stage transactions. | Finance |
Insilico Medicine IP Ltd.
Insilico Medicine IP Ltd. BiotechnologyHealth Technology Engages in research and development of drugs | Health Technology |
Insilicon Intelligent Technology Shanghai Co Ltd.
 Insilicon Intelligent Technology Shanghai Co Ltd. Miscellaneous Commercial ServicesCommercial Services Provides technical, technology and related consulting services | Commercial Services |
